Get the Stockscreener App
8.02
5.98%
-0.51
After Hours:
8.16
0.14
+1.75%
Achieve Life Sciences Inc Stock (ACHV) Forecast
The Achieve Life Sciences Inc (ACHV) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $38.83, representing a +384.14% increase from the current price of $8.02. The highest analyst price target is $39.08, and the lowest is $38.57.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ACHV Price Target
Average 33.36
(+315.90% Upside)
Is Achieve Life Sciences Inc (ACHV) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 69.08 | Neutral |
| STOCH(9,6) | 90.67 | Sell |
| STOCHRSI(14) | 51.54 | Neutral |
| MACD(12,26) | 0.4802 | Buy |
| ADX(14) | 37.55 | Buy |
| William %R | -24.48 | Neutral |
| CCI(14) | 136.32 | Buy |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
7.319
Buy
|
7.4608
Buy
|
| MA20 |
6.8273
Buy
|
7.0401
Buy
|
| MA50 |
6.3053
Buy
|
6.3815
Buy
|
| MA100 |
5.3849
Buy
|
5.7452
Buy
|
| MA200 |
4.952
Buy
|
4.975
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, ACHV could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 1 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on ACHV, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 69.08 indicates that ACHV is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 90.67 indicates that ACHV is oversold. This means that ACHV price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 51.54 indicates that ACHV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 37.55 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 136.32 indicates that ACHV is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term ACHV price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Achieve Life Sciences Inc financial reports and earnings history, Achieve Life Sciences Inc (ACHV) stock could reach $76.95 by 2030, $54.74 by 2040 and $179.11 by 2050. See the projected annual prices until 2050 of the Achieve Life Sciences Inc stock below:
- Achieve Life Sciences Inc (ACHV) is expected to reach an average price of $17.24 in 2035, with a high prediction of $20.68 and a low estimate of $17.61. This indicates an $114.99% rise from the last recorded price of $8.02.
- Achieve Life Sciences Inc (ACHV) stock is projected to chart a bullish course in 2040, with an average price target of $51.44, representing an $541.38% surge from its current level. The forecast ranges from a conservative $52.06 to a sky-high $54.74.
- Our analysts predict Achieve Life Sciences Inc (ACHV) to jump 1,268% by 2045, soaring from $109.75 to an average price of $109.70, potentially reaching $111.21. While $109.75 is the low estimate, the potential upside is significant.
- Achieve Life Sciences Inc (ACHV) stock is expected to climb by 2050, reaching an average of $175.54, a $2,089% jump from its current level. However, a wide range of estimates exists, with high and low targets of $179.11 and $176.86, respectively, highlighting the market's uncertainty.
Achieve Life Sciences Inc Stock (ACHV) Year by Year Forecast
Achieve Life Sciences Inc Stock (ACHV) Price Forecast for 2026
The predicted value for Achieve Life Sciences Inc (ACHV) in 2026 is set at an average of $41.48. Estimates vary from a peak of $47.69 to a trough of $35.28, indicating an +417.27% surge from the present price of $8.02.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| September, 2026 | $38.84 | $38.57 | $39.08 | +384.29% |
| October, 2026 | $38.68 | $38.88 | $38.31 | +382.30% |
| November, 2026 | $36.56 | $37.12 | $38.08 | +355.87% |
| December, 2026 | $35.15 | $35.28 | $36.09 | +338.26% |
Achieve Life Sciences Inc Stock (ACHV) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Achieve Life Sciences Inc (ACHV) is $30.14, with a high forecast of $34.54 and a low forecast of $25.74. This indicates an +275.81% increase from the last price of $8.02.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $34.39 | $34.89 | $34.54 | +328.79% |
| February, 2027 | $33.99 | $33.92 | $33.99 | +323.81% |
| March, 2027 | $33.05 | $33.77 | $33.54 | +312.06% |
| April, 2027 | $30.99 | $31.75 | $32.02 | +286.38% |
| May, 2027 | $30.78 | $31.20 | $31.21 | +283.77% |
| June, 2027 | $30.38 | $30.10 | $30.18 | +278.75% |
| July, 2027 | $28.51 | $28.94 | $29.64 | +255.44% |
| August, 2027 | $27.43 | $27.63 | $28.18 | +241.98% |
| September, 2027 | $26.81 | $27.38 | $27.02 | +234.35% |
| October, 2027 | $27.19 | $26.52 | $26.55 | +238.97% |
| November, 2027 | $26.59 | $26.98 | $27.04 | +231.49% |
| December, 2027 | $25.52 | $25.74 | $26.08 | +218.25% |
Achieve Life Sciences Inc Stock (ACHV) Price Forecast for 2028
In 2028, Achieve Life Sciences Inc (ACHV) is projected to reach an average price of $18.19, with a high projection of $25.11 and a low estimate of $11.27. This indicates an +126.79% rise from the last price of $8.02.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $24.92 | $25.15 | $25.11 | +210.77% |
| February, 2028 | $25.20 | $24.65 | $24.60 | +214.27% |
| March, 2028 | $25.03 | $24.99 | $24.94 | +212.12% |
| April, 2028 | $23.32 | $23.90 | $24.67 | +190.81% |
| May, 2028 | $22.47 | $22.61 | $23.02 | +180.18% |
| June, 2028 | $19.40 | $19.89 | $22.12 | +141.91% |
| July, 2028 | $17.59 | $17.94 | $18.51 | +119.35% |
| August, 2028 | $17.25 | $17.27 | $17.14 | +115.08% |
| September, 2028 | $13.62 | $14.10 | $16.74 | +69.83% |
| October, 2028 | $10.96 | $11.46 | $12.93 | +36.66% |
| November, 2028 | $11.67 | $11.27 | $12.23 | +45.49% |
| December, 2028 | $12.21 | $11.93 | $11.50 | +52.23% |
Achieve Life Sciences Inc Stock (ACHV) Price Forecast for 2029
The 2029 price forecast for Achieve Life Sciences Inc Stock (ACHV) is $34.53 on average, with a high prediction of $68.96 and a low estimate of $0.0963. This represents an +330.53% increase from the previous price of $8.02.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $10.54 | $10.66 | $11.89 | +31.38% |
| February, 2029 | $10.49 | $10.39 | $10.18 | +30.76% |
| March, 2029 | $9.4775 | $9.5875 | $9.8447 | +18.17% |
| April, 2029 | $9.3879 | $9.411 | $9.1675 | +17.06% |
| May, 2029 | $7.7359 | $7.9459 | $8.7555 | -3.54% |
| June, 2029 | $4.9963 | $5.0863 | $6.2935 | -37.70% |
| July, 2029 | $5.7067 | $5.2739 | $6.3891 | -28.84% |
| August, 2029 | $3.6347 | $3.6847 | $5.3143 | -54.68% |
| September, 2029 | $3.5951 | $3.5075 | $3.2759 | -55.17% |
| October, 2029 | $1.6931 | $1.8031 | $2.7628 | -78.89% |
| November, 2029 | $0.7735 | $1.0835 | $1.2267 | -90.36% |
| December, 2029 | $73.96 | $0.0963 | $68.96 | +822.19% |
Achieve Life Sciences Inc Stock (ACHV) Price Forecast for 2030
Achieve Life Sciences Inc Stock (ACHV) is expected to reach an average price of $102.52 in 2030, with a high forecast of $127.59 and a low forecast of $77.44. This signifies an +1,178% surge from the last price of $8.02.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $104.44 | $77.44 | $76.95 | +1,202% |
| February, 2030 | $117.02 | $108.53 | $111.82 | +1,359% |
| March, 2030 | $114.40 | $114.90 | $113.60 | +1,326% |
| April, 2030 | $108.58 | $111.78 | $110.89 | +1,254% |
| May, 2030 | $111.45 | $104.86 | $107.85 | +1,290% |
| June, 2030 | $114.08 | $114.44 | $113.44 | +1,322% |
| July, 2030 | $123.91 | $117.03 | $122.71 | +1,445% |
| August, 2030 | $129.59 | $123.21 | $120.21 | +1,516% |
| September, 2030 | $125.16 | $127.07 | $127.59 | +1,461% |
| October, 2030 | $124.02 | $124.19 | $123.85 | +1,446% |
| November, 2030 | $126.59 | $124.21 | $123.45 | +1,478% |
| December, 2030 | $124.54 | $124.71 | $125.23 | +1,453% |
1.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):